Earth Science Tech (ETST) Change in Accured Expenses (2012 - 2025)
Earth Science Tech (ETST) reported Change in Accured Expenses of -$1.3 million for Q4 2025, down 1045.99% on a YoY basis from $132584.9 in Q4 2024, and down 908.05% quarter-over-quarter from $155218.0 in Q3 2025.
Earth Science Tech (ETST) Change in Accured Expenses (2012 - 2025) Analysis & Trends
Earth Science Tech has reported Change in Accured Expenses for 10 years, with the latest figure at -$1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses fell 1045.99% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at $605013.0 (down 31.93% YoY), and the FY2025 full-year result was $1.4 million, up 64.59% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at -$1.3 million, down from $155218.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $3.4 million in Q4 2021, with the low at -$3.4 million in Q1 2021.
- Historically, Change in Accured Expenses has averaged $96345.6 across 5 years, with a median of $34396.0 in 2023.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses plunged 1663.51% — and 2025, when it surged 10622.08%.
- Earth Science Tech's Change in Accured Expenses stood at $3.4 million in 2021, then tumbled by 124.48% to -$839125.0 in 2022, then jumped by 100.83% to $7000.0 in 2023, then sank by 1663.51% to -$109446.0 in 2024, then plunged by 1045.99% to -$1.3 million in 2025.
- The last three Change in Accured Expenses figures came in at -$1.3 million (Q4 2025), $155218.0 (Q3 2025), and $330709.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Earth Science Tech | - | - | 6.40 Mn | -1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.25 Mn |
| Dec 31, 2025 | -1.25 Mn |
| Sep 30, 2025 | 155,218.00 |
| Sep 30, 2025 | 155,218.00 |
| Jun 30, 2025 | 330,709.00 |
| Jun 30, 2025 | 330,709.00 |
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | -109,446.00 |
| Dec 31, 2024 | -109,446.00 |
| Sep 30, 2024 | 168,192.00 |
| Sep 30, 2024 | 168,192.00 |
| Jun 30, 2024 | -3,143.00 |
| Jun 30, 2024 | -3,143.00 |
| Mar 31, 2024 | 833,176.00 |
| Mar 31, 2024 | 833,176.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | -33,792.00 |
| Sep 30, 2023 | -33,792.00 |